News Results

There are 647,617 News Results

Feb 17, 2021
CenterPoint Energy Announces Its Support of the Proposed Merger Between Enable Midstream Partners, LP and Energy Transfer LP
CenterPoint Energy, Inc. (NYSE: CNP) today announced support for the merger between Enable Midstream Partners, LP (NYSE: ENBL) and Energy Transfer LP (NYSE: ET), which will result in an exchange...
Feb 18, 2021
indie Semiconductor Augments Senior Management Team
indie Semiconductor, an Autotech solutions innovator which is currently in the process of becoming a public company through a planned merger with Thunder Bridge Acquisition II (Nasdaq: THBR), a special...
Feb 18, 2021
Ensysce Biosciences, Inc. And Leisure Acquisition Corp. Announce Appointment Of Dave Humphrey As Chief Financial Officer
NEW YORK and SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- Ensysce Biosciences Inc. ("Ensysce"), a clinical stage pharmaceutical company developing medicines for severe pain relief to reduce fear of addiction,...
Feb 23, 2021
Arconic Reports Fourth Quarter 2020 and Full Year 2020 Results
Arconic Corporation (NYSE: ARNC) (“Arconic” or “the Company”) today reported fourth quarter 2020 and full year 2020 results. Fourth Quarter 2020 Results The Company reported revenue of $1.5 billion, up...
Feb 23, 2021
RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ --
Feb 23, 2021
indie Semiconductor Provides Merger and Business Update
indie Semiconductor, an Autotech solutions innovator which is currently in the process of becoming a public company through a planned merger with Thunder Bridge Acquisition II (Nasdaq: THBR), a special...
Feb 24, 2021
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA by ViiV Healthcare for Expanded Use of CABENUVA (rilpivirine and cabotegravir) as an HIV Treatment for Use Every Two Months
TITUSVILLE, N.J., Feb. 24, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S....
Feb 25, 2021
Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
RED BANK, N.J., Feb. 25, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the fourth...
Feb 26, 2021
Evergy Announces 2020 Results at Top End of Guidance Range, Declares Quarterly Dividend, and Issues 2021 Outlook
Evergy, Inc. (NYSE: EVRG) today announced full year GAAP 2020 earnings of $618 million, or $2.72 per share, compared with earnings of $670 million, or $2.79 per share, for the...
Mar 3, 2021
ExxonMobil Outlines Plans to Grow Long-Term Shareholder Value in Lower Carbon Future
ExxonMobil today outlined its plans through 2025 to increase earnings and cash flow to sustain and grow its dividend, reduce debt and fund advantaged projects, while working to commercialize lower...
64762

Pages

1

Stories of the day

Sep 17, 2025
Babcock signs new $250 million contract with Australian Border Force to keep...
Sep 19, 2025
CACI to Deliver Secure, Reliable Communications to the Air Force – Pacific Air...
Sep 19, 2025
Saab to lead NATOs new underwater battlespace project
Sep 19, 2025
Babcock and BAE Systems Bofors coordinate capabilities for gunnery support